Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
SunWay Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

NT$90.3

2024-10-29

Market Capitalization

NT$5.4 B

2024-10-29

Revenue

NT$970.2 M

FY, 2024

CreditSafe Score

?
Score changed on Jun 15, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

TWDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024
Revenue108.7M172.2M314.5M380.4M350.4M571.1M970.2M
Cost of goods sold45.2M41.8M85.7M89.6M71.7M309.5M341.5M
Gross profit76.0M133.1M228.9M294.1M279.1M262.4M629.7M
Gross profit margin, %70.0%77.3%72.8%77.3%79.6%45.9%64.9%
Operating expense total70.2M66.6M82.6M103.4M111.1M183.6M404.1M
Depreciation and amortization13.3M21.7M20.3M19.7M23.3M24.9M83.6M
EBITDA5.8M66.5M146.4M190.7M168.0M78.8M225.6M
EBITDA margin, %5.4%38.6%46.5%50.1%47.9%13.8%23.2%
EBIT(7.5M)44.9M126.0M170.8M144.7M53.9M142.0M
EBIT margin, %-6.9%26.0%40.1%44.9%41.3%9.4%14.6%
Interest income62.0K54.0K44.0K58.0K421.0K1.8M3.0M
Interest expense764.0K638.0K195.0K90.0K2.7M2.1M5.5M
Pre tax profit(11.1M)39.6M125.7M170.2M143.5M56.2M142.1M
Income tax expense2.5M1.4M488.0K7.9M9.8M23.5M
Net Income(13.5M)38.2M125.7M169.7M135.6M46.4M118.6M

Footer menu